Jennifer Permuth-Wey,Donghwa Kim,Ya-Yu Tsai,Hui-Yi Lin,Y. Ann Chen,Jill Barnholtz-Sloan,Michael J. Birrer,Gregory Bloom,Stephen J. Chanock,Zhihua Chen,Daniel W. Cramer,Julie M. Cunningham,Getachew Dagne,Judith Ebbert-Syfrett,David Fenstermacher,Brooke L. Fridley,Montserrat Garcia-Closas,Simon A. Gayther,William Ge,Aleksandra Gentry-Maharaj,Jesus Gonzalez-Bosquet,Ellen L. Goode,Edwin Iversen,Heather Jim,William Kong,John McLaughlin,Usha Menon,Alvaro N.A. Monteiro,Steven A. Narod,Paul D.P. Pharoah,Catherine M. Phelan,Xiaotao Qu,Susan J. Ramus,Harvey Risch,Joellen M. Schildkraut,Honglin Song,Heather Stockwell,Rebecca Sutphen,Kathryn L. Terry,Jonathan Tyrer,Robert A. Vierkant,Nicolas Wentzensen,Johnathan M. Lancaster,Jin Q. Cheng,Thomas A. Sellers

Supplementary Table 1 from Gene Alterations Identified by Expression Profiling in Tumor-Associated Endothelial Cells from Invasive Ovarian Carcinoma

Supplementary Table 1 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Supplementary Table S2 from <i>LIN28B</i> Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Table 2 from Inherited Variants in Mitochondrial Biogenesis Genes May Influence Epithelial Ovarian Cancer Risk

Supplementary Table S4 from <i>LIN28B</i> Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Table S1 from <i>LIN28B</i> Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Table S3 from <i>LIN28B</i> Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Table 2 from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER<sup>+</sup> Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes

Supplementary Table 1 from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER<sup>+</sup> Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes

Supplementary Table 3 from Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer

Supplementary Tables 4 - 8 from Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome

Supplementary Tables from Immunogenomic Analyses of Advanced Serous Ovarian Cancer Reveal Immune Score is a Strong Prognostic Factor and an Indicator of Chemosensitivity

Supplementary Table 1 from Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer

Supplementary Table 2 from Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer

Supplementary Table from Single-Cell Dissection of the Multiomic Landscape of High-Grade Serous Ovarian Cancer

Supplementary Table 3 from Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors

Supplementary Table and Figure Legends from Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer

Supplementary Tables from Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer

Supplementary Information from Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

Supplementary Table 1 from Identification of an Integrated SV40 T/t-Antigen Cancer Signature in Aggressive Human Breast, Prostate, and Lung Carcinomas with Poor Prognosis

Supplementary Table 4 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes